These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1871328)

  • 1. Haloperidol reductase activity in red blood cells from oriental patients on haloperidol.
    Someya T; Shibasaki M; Kato T; Noguchi T; Ishida N; Takahashi S
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):275-8. PubMed ID: 1871328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of plasma and red blood cells reduced haloperidol concentrations to haloperidol reductase activity assayed in red blood cells in psychiatric population.
    Shibasaki M; Someya T; Takahashi S
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Mar; 17(2):257-67. PubMed ID: 8430218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of haloperidol reductase activity in red blood cells and reduced haloperidol/haloperidol ratios in plasma in oriental psychiatric patients.
    Shibasaki M; Someya T; Kato T; Noguchi T; Ishida N; Takahashi S
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):941-7. PubMed ID: 2277853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol metabolism in psychiatric patients: importance of glucuronidation and carbonyl reduction.
    Someya T; Shibasaki M; Noguchi T; Takahashi S; Inaba T
    J Clin Psychopharmacol; 1992 Jun; 12(3):169-74. PubMed ID: 1629382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced haloperidol/haloperidol ratios in plasma: polymorphism in Japanese psychiatric patients.
    Someya T; Takahashi S; Shibasaki M; Inaba T; Cheung SW; Tang SW
    Psychiatry Res; 1990 Feb; 31(2):111-20. PubMed ID: 2326392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of the determination of erythrocyte haloperidol ketone reductase activity in the evaluation of haloperidol therapy].
    Dutoit D; Leroux JM; Vaiva G; Mohamed Y; Thomas P; Pommery J; Taret I; Bianchi-Decaix I; Erb F; Goudemand M
    Therapie; 1994; 49(1):71-4. PubMed ID: 8091373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoclinical correlations in schizophrenic patients treated with haloperidol decanoate: clinical evaluations, concentrations of plasma and red blood cell haloperidol and its reduced metabolite, and plasma homovanillic acid.
    Aymard N; Viala A; Stein I; Caroli F
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov; 19(7):1119-35. PubMed ID: 8787036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced haloperidol: a factor in determining the therapeutic benefit of haloperidol treatment?
    Chang WH
    Psychopharmacology (Berl); 1992; 106(3):289-96. PubMed ID: 1570373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent reduced haloperidol/haloperidol ratios in schizophrenic patients.
    Chang WH; Hwu HG; Lane HY; Lin SK; Chen TY; Chen H; Wei HL; Lin WL; Lin HN
    Psychiatry Res; 1991 Sep; 38(3):215-25. PubMed ID: 1754634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R
    Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cytochrome P450 2D6 genotypes on haloperidol metabolism: a preliminary study in a psychiatric population.
    Someya T; Suzuki Y; Shimoda K; Hirokane G; Morita S; Yokono A; Inoue Y; Takahashi S
    Psychiatry Clin Neurosci; 1999 Oct; 53(5):593-7. PubMed ID: 10595685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients.
    Chang WH; Lin SK; Jann MW; Lam YW; Chen TY; Chen CT; Hu WH; Yeh EK
    Biol Psychiatry; 1989 Jul; 26(3):239-49. PubMed ID: 2742942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients.
    Pan L; Vander Stichele R; Rosseel MT; Berlo JA; De Schepper N; Belpaire FM
    Ther Drug Monit; 1999 Oct; 21(5):489-97. PubMed ID: 10519444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interconversions between haloperidol and reduced haloperidol in schizophrenic patients and guinea pigs: a steady-state study.
    Chang WH; Lin SK; Jann MW
    J Clin Psychopharmacol; 1991 Apr; 11(2):99-105. PubMed ID: 2056148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The plasma levels of haloperidol and reduced haloperidol in Japanese psychiatric patients].
    Someya T; Shibasaki M; Takahashi S
    Yakubutsu Seishin Kodo; 1989 Jun; 9(2):207-15. PubMed ID: 2816093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of CYP2D6 genotypes on the metabolism of haloperidol in a Japanese psychiatric population.
    Someya T; Shimoda K; Suzuki Y; Sato S; Kawashima Y; Hirokane G; Morita S; Yokono A; Takahashi S
    Neuropsychopharmacology; 2003 Aug; 28(8):1501-5. PubMed ID: 12784098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interindividual variation in bromperidol metabolism and relationship to therapeutic effects.
    Someya T; Muratake T; Hirokane G; Shibasaki M; Shimoda K; Takahashi S
    J Clin Psychopharmacol; 2000 Apr; 20(2):175-80. PubMed ID: 10770455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
    Neborsky RJ; Janowsky DS; Perel JM; Munson E; Depry D
    J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
    Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J
    Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.